Form 4: Aptiv PLC CEO Kevin Clark Reports Changes in Beneficial Ownership
SEC Form 4 Filing
A Form 4 filing reveals Aptiv PLC CEO Kevin Clark's transactions involving ordinary shares, including disposal due to below-target performance and vesting of restricted stock units.
Summary
- On February 28, 2025, Kevin Clark, the Chair and CEO of Aptiv PLC, reported changes in his beneficial ownership of Aptiv ordinary shares.
- He disposed of 20,026 shares back to the issuer due to below-target performance during the 2022-2024 performance period.
- Additionally, 39,627 shares were withheld to cover tax liabilities related to the vesting of restricted stock units at a price of $65.12 per share.
- Clark also acquired 87,062 shares that will vest in three equal installments beginning on the first anniversary of the date of grant.
- He acquired 130,591 performance shares, each representing a contingent right to receive an ordinary share, vesting based on performance criteria from January 1, 2025, to December 31, 2027.
- Following these transactions, Clark directly owns 492,170 ordinary shares and indirectly owns 624,344 shares through the Kevin P. Clark Revocable Trust.
Sentiment
Score: 6
Explanation: The sentiment is neutral. While there was a disposal of shares due to below-target performance, there were also acquisitions of shares, including performance-based shares, indicating a mixed outlook.
Positives
- Kevin Clark acquired 87,062 shares that will vest in three equal installments beginning on the first anniversary of the date of grant.
- He also acquired 130,591 performance shares, each representing a contingent right to receive an ordinary share, vesting based on performance criteria from January 1, 2025, to December 31, 2027.
Negatives
- Kevin Clark disposed of 20,026 ordinary shares due to below-target performance during the 2022-2024 period.
Risks
- The disposal of shares due to below-target performance could signal concerns about the company's recent performance.
- The vesting of performance shares is contingent on achieving specific performance criteria, which may not be met.
Future Outlook
The vesting of performance shares is contingent upon the achievement of specified performance criteria over a period from January 1, 2025 to December 31, 2027.
Industry Context
Executive stock transactions are closely watched as indicators of management's confidence in the company's future prospects. Disposals can sometimes raise concerns, while acquisitions are generally seen as positive signals.
Comparison to Industry Standards
- Executive compensation packages often include performance-based equity grants to align management's interests with those of shareholders.
- The vesting schedules and performance criteria for these grants vary across companies and industries.
- Comparing Aptiv's executive compensation structure to that of its peers, such as Visteon or Magna International, could provide further context.
Stakeholder Impact
- Shareholders may be concerned about the disposal of shares due to below-target performance.
- Employees may be affected by the company's overall performance, which impacts the vesting of performance shares.
Next Steps
- Monitor Aptiv's performance against the specified criteria for the vesting of performance shares.
- Track future insider transactions to gauge management's evolving sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of the reported transactions. |
| 03/04/2025 | Date of signature of the report. |
| January 1, 2025 | Start date of the performance period for performance shares. |
| December 31, 2027 | End date of the performance period for performance shares. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.